Active Biotech and SmithKline Beecham Agree to Close Collaboration Regarding Vaccines Against Traveller's Diarrhoea.Business Editors & Health/Medical Writers STOCKHOLM, Sweden--(BUSINESS WIRE)--Aug. 8, 2000 Active Biotech has taken back the worldwide rights for the ETEC ETEC enterotoxigenic Escherichia coli. ETEC Enterotoxic Escherichia coli, see there vaccine project. The ongoing phase III clinical trials in Mexico and Guatemala are continuing according to plan. Alternative partnering strategies are under evaluation as well as the future clinical trials program. Furthermore, all the international marketing rights for the SBL SBL Society of Biblical Literature SBL Symbol Technologies, Inc. (NYSE symbol) SBL Spamhaus Block List SBL Space-Based Laser SBL Securities Borrowing and Lending SBL Supreme Beings of Leisure (band) Cholera Vaccine have been transferred back to Active Biotech. As part of the agreement, SmithKline Beecham's (SB) paediatric Adj. 1. paediatric - of or relating to the medical care of children; "pediatric dentist" pediatric vaccines, currently sold by Active Biotech through SBL Vaccin under an agreement that were to expire 2003, will be transferred to the Nordic organisation of SB from 1 January 2001. In line with Active Biotech's strategy to focus on vaccines for travellers, Active will receive a license for Sweden from SB regarding a second brand of their product HAVRIX, a vaccine to prevent hepatitis A infections. This product will be marketed by Active Biotech's Swedish marketing organisation SBL Vaccin. These changes are not estimated to have any effect on the result of Active Biotech for the years 2000-2001. Lund 8 August 2000 Active Biotech (Publ) Sven Andreasson President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Active Biotech AB is a Swedish biotechnology company focused on the research and development of pharmaceuticals and vaccines, the core competence being knowledge of the human immune system. Active Biotech has a high quality project portfolio and considerable financial resources. Important products and projects include Dukoral, SBLCholera Vaccine, a vaccine against traveller's diarrhoea (ETEC), innovative drugs against MS (SAIK SAIK Sandvikens Aik ) and cancer (TTS (1) See text-to-speech. (2) (Transaction Tracking System) Software that monitors a transaction until completion. In the event of a hardware or software failure, it ensures that the database is brought back to its former state before the attempt to ). The turnover of Active Biotech was SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 267 million in 1999. Active Biotech AB Box 724, S-220 07 Lund, Sweden Tel +46 46-19 20 00 Fax +46 46 19 20 50 E-mail info@activebiotech.com www.activebiotech.com www.activebiotech.com This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2000/08/08/20000808BIT00180/bit0001.doc http://www.bit.se/bitonline/2000/08/08/20000808BIT00180/bit0002.pdf |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion